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Background: Ischemia/reperfusion (IR) is a main cause of acute
kidney injury (AKI). Up-regulated caspase-3, a key enzyme involved in
inflammation and apoptosis, was revealed in renal IR injury and
reversed by a novel cyclic helix B peptide (CHBP), derived from erythro-
poietin. Here, caspase-3 small interfering RNA (C3siRNA) and/or CHBP
were applied in a mouse model to further explore underlying
mechanisms.
Methods: Bilateral renal occlusion for 30 min was performed in male C57BL/
6 mice and followed by 48 h reperfusion. 0.03 mg/kg C3siRNA or its negative
control (NC) was injected intravenously 2 h before ischemia. 24 nmol/kg
CHBP was injected intraperitoneally post reperfusion. Serum and kidney
samples were collected for renal function, histology and molecular biology
analyses.
Results: Serum creatinine and tubulointerstitial damage (TID) score were
increased by IR injury, but decreased by C3siRNA and/or CHBP (all
P < 0.01). In addition, the expression of 17 kD active caspase-3, active cas-
pase-3+ cells and apoptotic cells were raised by IR injury, but reduced by
C3siRNA and/or CHBP (P < 0.01). More interestingly, there was a significant
reduction in TID in the kidneys treated with both C3siRNA and CHBP
compared with its sole treatment.
Conclusion: C3siRNA and CHBP ameliorated IR injury, both of which
might have certain synergetic effects. CHBP might reduce active cas-
pase-3, subsequently affect apoptosis, and improve renal function and
structure.http://dx.doi.org/10.1016/j.hkjn.2015.09.0510025
Incidence and Outcome of Acute Kidney Injury in Hospitalized Patients
in a Single Center
Wang Yimei1,2, Teng Jie1,2, Zou Zhouping1,2, Xu Jiarui1,2, Jiang Wuhua1,2,
Ding Xiaoqiang1,2
1Division of Nephrology, Fudan University Zhongshan Hospital, Shanghai,
China
2Shanghai Institute for Kidney and Dialysis, Shanghai, China
Objective: This study was to determine the incidence and mortality rate of
acute kidney injury (AKI) among hospitalized adult patients in a tertiary
metropolitan hospital of China, and to evaluate the impact of AKI on 28-
day mortality, cost and length of stay (LOS).
Methods: Patients of Zhongshan Hospital, Fudan University, Shanghai be-
tween November 3rd, 2014 and November 9th, 2014 were screened by the
hospital medical database. The presence and severity of AKI were assessed
by the KDIGO criteria. Follow-up biochemical and clinical data were used to
determine short-term (28 days) outcomes.
Results: There were 2563 patients during the study period and 92 (3.59%)
met the diagnostic criteria of AKI. The median age of AKI patients was 64
years, 70.7% were male, 12% received renal replacement therapy. 23 pa-
tients (25%) were community-acquired AKI, the leading cause was nephro-
toxic drugs (26.1%), infection (21.7%) and heart failure (17.4%). Hospital-
acquired AKI was 75%, the leading cause was surgery (62.7%), infection
(14.5%) and nephrotoxic drugs (8.7%). The AKI group had significantly
longer LOS than the non AKI group (14 vs. 6 days). The 28d mortality of
AKI was 7.6%. Complete, partial and no renal recovery was observed in
28.3%, 23.9% and 21.7% of the patients, respectively. Of AKI patients,
AKI stage (KDIGO criteria), malignancy and albumin were independent
risk factors of 28-day mortality according to multivariate logistic
regression.
Conclusion: AKI is prevalent in the Chinese hospitalized patients. Slight el-
evations of serum creatinine are associated with significantly increased mor-
tality, LOS and hospital cost. Moreover, outcomes are related directly to the
severity of AKI.http://dx.doi.org/10.1016/j.hkjn.2015.09.0520026
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Background: Emerging evidence indicates that retinoid-related orphan re-
ceptor alpha (RORalpha), a member of the ROR subfamily of nuclear recep-
tors, mediates key cellular adaptions to hypoxia and contributes to
pathophysiology of many disease states. However, the potential renal func-
tions of RORalpha in response to ischemia/reperfusion (I/R) injury remain
unclear. Here, we investigated the renal expression and biological function
of RORalpha in acute kidney injury (AKI).
Methods: I/R injury was induced by 35 min bilateral clamping of the renal
pedicle and 24 h reperfusion in wild-type and staggerer [RORalpha(sg/sg)]
mice, a natural mutant strain lacking RORalpha expression. Renal injury
and RORalpha abundance were analyzed. In addition, human proximal
tubular cell line (HK-2) was used to investigate the expression of RORalpha
under hypoxia.
Results: RORalpha was detected in both mouse renal endothelial and tubular
epithelial cells. Significant up-regulation of RORalpha was found after renal
I/R injury. Compared with wild-type, RORalpha(sg/sg) mice displayed signif-
icantly increased levels of serum creatinine (2.30 0.21 vs. 1.18 0.35 mg/
dl, p < 0.01), renal tissue damage, and pro-inflammatory cytokine produc-
tion after ischemic kidney injury (Figure 1). Further mechanistic studies indi-
cated that RORalpha agonists enhanced transcriptional activity of hypoxia-
inducible factor 1alpha (HIF-1alpha) in HK-2 cells, which was abolished by
siRNA-mediated silencing of endogenous RORalpha.
